Aurobindo Pharma Ltd
Nifty 200
Nifty 500
Midcap 50
Midcap 100
Midcap 150
LargeMid 250
F&O
₹1,679.80
+0.68%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.21.
- Comfortable interest cover: operating profit covers interest about 17.9 times.
- Return on equity is moderate at 10.1%.
- Return on capital employed is moderate at 12.9%.
- Net profit margin is 10.4%.
- Pays a dividend (yield about 0.24%).
- Has paid a dividend in 4 of the last 5 years.
- Promoters hold a majority stake (51.88%).
!Watch-points
- Profit growth has been slow over five years (about 1% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.86
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 96,652 Cr
Current Price₹ 1,679.80
High / Low₹ 1,717.00 / 1,066.80
Stock P/E26.2182
Book Value₹ 652.00
Dividend Yield0%
ROCE12.90%
ROE10.10%
Face Value₹ 1.00
Debt to Equity0.21
PEG Ratio1.10
EV / EBITDA11.93
Industry PE35.25
P/B Ratio2.5748363
EPS₹ 60.34
Debt₹ 8,073 Cr
PAT Margin10.41%
Cash PAT₹ 5,281 Cr
ICR17.89
Promoter Holding51.88%
FII Holding16.38%
DII Holding25.05%
Public Holding6.63%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity